Alertan que el Acuerdo Transpacífico complica el acceso a medicamentos

30-Jul-2015 La República Cierre de negociaciones. Técnicos del Mincetur, Minsa y Cancillería están ya en Hawái negociando mesa de Propiedad Intelectual antes de la llegada de Silva.

  • 3-Jul-2013 MSF
    Trans-Pacific trade deal threatens access to affordable medicines

    As host to both the AIDS conference and TPP trade talks this month, Malaysia reportedly vows to reject a TPP trade agreement that harms access to medicines; other countries should follow suit, and Malaysia should be held to its pledge

  • 30-Jun-2013 South Centre
    Investment agreements: A new threat to health and TRIPS flexibilities?

    Bilateral investment treaties (BITs) may be a threat to access to medicines as shown by a recent legal suit by a drug multinational against Canada for invalidating a patent, writes Carlos Correa

  • 17-Jun-2013 Mondaq
    A Kiwi-sized "Spanner in the works" of the TPP?

    Are the PBS and Pharmac under threat from the TPP? Certainly, the respective governments of both Australia and New Zealand think not. So why then the paranoia? Quite simply, we need the US more than they need us. In order to secure the TPP (and with it, for example, access to the lucrative US dairy market), both Australia and New Zealand will likely need to yield in several key areas.

  • 21-May-2013 Infojustice
    Live from the TPP: IP chapter shows no sign of resolution, end of negotiation in 2013 highly unlikely

    There is a strong sense in the halls of the current TPP negotiation that the end is not in sight. And one of the primary reasons s a lack of consensus on intellectual property and pharmaceuticals issues, reports Infojustice from Lima.

  • 25-Apr-2013 Infojustice
    Investors’ IP rights unbound: The danger of investment clauses to access to medicines

    Although access to medicines activists have been wise to focus our attention intently on convincing low- and middle-income countries to adopt and use all possible TRIPS-compliant flexibilities and to oppose the TRIPS-plus IP chapters in free trade agreements, we have neglected to interrogate another chapter in free trade agreements and bilateral investment treaties that perhaps pose an even greater threat to our collective access to medicines – investment chapters.

  • 13-Apr-2013
    India-EU FTA won’t hit generic drugs industry: EU envoy

    The much-hyped bilateral trade and investment agreement (BTIA) between India and the European Union (EU) would not impact the Indian generic drugs industry or lead to a change in the country’s patent law, João Cravinho, EU ambassador to India, said on Friday.

  • 12-Apr-2013 HispanTV
    Indios rechazan la firma de un TLC con Unión Europea

    Centenares de activistas y empleados del sector de salud de La India protagonizaron el miércoles una manifestación multitudinaria para protestar contra la posible firma de un Tratado de Libre Comercio (TLC) entre su país y la Unión Europea (UE).

  • 11-Apr-2013 Firstpost
    India-EU FTA will imperil lives, local industry, say activists

    A large number of people living with HIV, cancer patients and health activists took to the streets of Delhi today asking government of India not to sign a Free Trade Agreement (FTA) with the European Union (EU) as it would be detrimental to the interests of tens of thousands of people like them in the country.

  • 10-Apr-2013 Infojustice
    Cambodian people’s statement on the EU-India free trade agreement on generic drugs

    We, Cambodian garment workers, sex workers, entertainment workers, people living with HIV, LGBTs, university students, feminists and human right activists from different networks and organisations came together to express our concern about the threat posed by the forthcoming EU-India free trade agreement to the lives of millions of people in Cambodia and many other developing countries across the world.

  • 10-Apr-2013 Act Up Paris
    Semaine internationale d’action contre les accords de libre-échange

    Du 9 au 15 avril 2013, les activistes et associations de lutte contre le sida et de défense de la santé du monde entier s’unissent pour lutter contre la stratégie commercial mortelle de la Commission et envoient a l’europe un message clair : les attaques contre les médicaments génériques doivent cesser maintenant

  • 10-Apr-2013 Act Up Paris
    L’accord de libre-échange entre l’UE et l’Inde met des millions de vies en danger

    Des militants de différents pays européens et des euro-députés se réunissent devant le Parlement européen pour réclamer l’abandon de dispositions mettant en danger l’accès aux médicaments.

  • 9-Apr-2013
    Join the rally to oppose EU-India FTA!

    Around 2000 people including people living with HIV (PLHIV), patient groups and public health activists will take to the streets and rally from Barakhamba road to Jantar Mantar at 11.00 am on 10 April 2013 to voice concerns and protest against harmful provisions being pushed by the EU-India FTA negotiations

  • 2-Apr-2013 First Post
    Manmohan Singh must learn from the Novartis judgement

    Will Manmohan Singh understand the clear purpose behind the national sentiment around the Supreme Court judgment on Novartis’ cancer drug Glivec? If he does, he should take a relook at the India-EU Free Trade Agreement that is cooking in his back-room.

  • 1-Apr-2013 LiveMint
    European Union sets tough conditions under FTA

    The gains accruing to the Indian generic drugs industry as a result of the Supreme Court judgement on the Novartis case may be lost if India accepts demands by the European Union (EU) under the proposed free trade agreement (FTA) between the two sides.

  • 27-Mar-2013
    Indian pharma sector fears India-European Union FTA could imperil local industry

    Drugmakers and healthcare activists are worried that the India-European Union Free Trade Agreement (FTA), which is in the works, may contain a provision that could imperil local industry and have urged the government to keep patent infringement issues out of FTAs.

  • 21-Mar-2013
    European Union-India FTA may hit generic medical industry

    The free trade agreement that European Union is pushing India to sign could put an end to India’s status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade agreements (FTAs) has submitted its report.

  • 12-Mar-2013 New Medical
    Trans-Pacific Partnership Agreement: an interview with Judit Rius, Médecins Sans Frontières

    The TPP negotiators are making decisions that will affect at least 600 million people, and potentially hundreds of millions more, in complete secrecy, and this is unacceptable.

  • 6-Mar-2013
    EU-Thailand FTA negotiations: What fate for access to medicines?

    Health Action International Europe, Oxfam and Action against AIDS Germany have serious concerns over the repercussions the EU-Thailand FTA will have on access to medicines in Thailand and the region.

  • 5-Mar-2013 MSF
    As clock ticks toward Trans-Pacific trade pact deadline, US must end stall tactics on access to medicines

    As closed-door talks for the Trans-Pacific Partnership Agreement resume in Singapore this week, international medical humanitarian organization Médecins Sans Frontières calls on the US government to end its stall tactics and revise its proposals for what otherwise promises to be the most harmful trade deal ever for access to medicines in developing countries.

  • 1-Mar-2013 ABC
    TLC con UE hace peligrar los genéricos contra el sida en Tailandia, según ONG

    La fundación AIDS Access afirmó hoy que el tratado de libre comercio (TLC) entre Tailandia y la Unión Europea (UE) pondrá en peligro el acceso de los enfermos de sida a los medicamentos genéricos en el país asiático.

  • 0 | 20 | 40 | 60 | 80 | 100 | 120 | 140 | 160 | ... | 600